| 000 | 01855 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515022835.0 | ||
| 264 | 0 | _c20060530 | |
| 008 | 200605s 0 0 eng d | ||
| 022 | _a0022-3050 | ||
| 024 | 7 |
_a10.1136/jnnp.2005.085019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilliams-Gray, C H | |
| 245 | 0 | 0 |
_aPrevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort. _h[electronic resource] |
| 260 |
_bJournal of neurology, neurosurgery, and psychiatry _cMay 2006 |
||
| 300 |
_a665-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aEngland |
| 650 | 0 | 4 | _aExons |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenes, Dominant |
| 650 | 0 | 4 | _aGenetic Carrier Screening |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlycine _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease _xdiagnosis |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aSerine _xgenetics |
| 700 | 1 | _aGoris, A | |
| 700 | 1 | _aFoltynie, T | |
| 700 | 1 | _aBrown, J | |
| 700 | 1 | _aMaranian, M | |
| 700 | 1 | _aWalton, A | |
| 700 | 1 | _aCompston, D A S | |
| 700 | 1 | _aSawcer, S J | |
| 700 | 1 | _aBarker, R A | |
| 773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 77 _gno. 5 _gp. 665-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp.2005.085019 _zAvailable from publisher's website |
| 999 |
_c16218934 _d16218934 |
||